Cargando…

Maintaining remission in ulcerative colitis – role of once daily extended-release mesalamine

The aminosalicylates (5-ASA; also referred to as mesalamine-based agents) are considered as first-line in the maintenance of remission of mild to moderate ulcerative colitis (UC). Traditionally these agents have required a large pill burden and multiple daily dosing regimens which may account for th...

Descripción completa

Detalles Bibliográficos
Autores principales: Oliveira, Lilliana, Cohen, Russell D
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3063115/
https://www.ncbi.nlm.nih.gov/pubmed/21448448
http://dx.doi.org/10.2147/DDDT.S5392